Get a psychological profile on anyone - identify traits and risks of mental illness. (Get started for free)

Can Vyvanse be an effective treatment for binge eating disorder and reducing compulsive food cravings?

Vyvanse is primarily used to treat attention deficit hyperactivity disorder (ADHD), but research suggests it can also effectively reduce binge eating episodes and symptoms in individuals with binge eating disorder (BED).

A study published in the Journal of Clinical Psychopharmacology found that Vyvanse significantly reduced the number of binge eating days per week and improved symptoms of depression and anxiety in patients with BED.

Vyvanse works by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain, which can help regulate impulse control and reduce the urge to binge eat.

Vyvanse has been shown to reduce body mass index (BMI) in individuals with BED, which can be a significant benefit for those struggling with weight-related issues.

Vyvanse is not currently approved by the FDA for the treatment of BED, but it may be prescribed off-label by healthcare providers for this purpose.

Cognitive-behavioral therapy (CBT) is a type of therapy approach that aims to help individuals change their behaviors and is an alternative treatment option for BED.

Vyvanse is not an appetite suppressant and should not be used solely for the purpose of losing weight or in the treatment of obesity outside of the context of BED.

Vyvanse is associated with serious side effects, including psychosis, manic symptoms, sudden death, heart attack, and rapid heart rate.

Lisdexamfetamine, the active ingredient in Vyvanse, was first approved in 2007 as a once-daily medication for ADHD in patients aged 6 and older.

Vyvanse is a Schedule II controlled substance because it has a high potential for abuse and dependence.

According to the Agency for Healthcare Research and Quality, binge eating disorder affects up to 3.5% of adults in the United States.

Vyvanse is the first FDA-approved drug to treat binge eating disorder in adults, but it is not approved to treat BED in children.

To diagnose binge eating disorder, a mental health professional may recommend a mental health evaluation, which includes talking about feelings and eating habits.

A study published in the International Journal of Eating Disorders found that Vyvanse was associated with significant reductions in binge eating frequency and severity.

A meta-analysis of data pooled from three acute randomized controlled trials found that lisdexamfetamine significantly reduced the Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating total score, weight response, and remission rates, and had higher discontinuation rates due to treatment-emergent adverse events.

Get a psychological profile on anyone - identify traits and risks of mental illness. (Get started for free)

Related

Sources